Search

everythinglearnresearchcommunity

for

Search:↓

More effective treatments are needed for alopecia areata, hidradenitis suppurativa, and vitiligo.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Early biopsy and targeting inflammation can improve treatment for hair loss in androgenetic alopecia.

IL-1β inhibits human hair follicle growth.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

IL-18 signaling helps mature Tregs move into the thymus.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

Statins may help treat alopecia areata by reducing harmful immune interactions.

Two men experienced hair regrowth while being treated with immune globulin for other health issues, but there were also side effects.

Apremilast did not work for treating severe alopecia areata.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

A sphingolipid from human placenta may help treat vitiligo by activating melanocyte stem cells.

Topical tacrolimus reduces certain growth factors in hair follicles.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.